Skip to main content
. 2021 Sep 27;14:17562864211042458. doi: 10.1177/17562864211042458

Figure 1.

Figure 1.

Tysabri Observational Program (TOP) patients included in propensity score matching.

EID, extended interval dosing; Q4W, every 4 weeks; Q6W, every 6 weeks.

*Other includes infusion records with missing dates (n = 13), no Q4W infusion history (switch occurred prior to 2014; n = 5), and multiple switches between Q4W and Q6W (n = 22).